BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification Peptides! Update as of 4.15.26 from the FDA. We will know more in July. This will allow these previously labeled category 2 research peptides to category 1 and allowable for compounding by BPC 157: Experimental Peptide Creates Risk for Athletes The Pharmacology of Longevity: Peptide Edition (Part 1) Is BPC 157 Banned? Oral vs. Injectable Forms Explained